Michael Field
Michael Field
Japan's experience with living-donor kidney transplantation across ABO barriers [0.03%]
日本ABO血型不相容活体肾移植的经验
Naotsugu Ichimaru,Shiro Takahara
Naotsugu Ichimaru
Given the severe shortage of deceased-donor organs in Japan, the use of living-donor kidney transplantation (LKT) strategies, such as ABO-incompatible living-donor kidney transplantation, has expanded rapidly. ABO-incompatible LKT was initi...
Robert A Bray,Howard M Gebel
Robert A Bray
This commentary discusses the strengths and weaknesses of a recent study reported by Kobayashi and colleagues, in which paired serum samples from 297 renal transplant recipients who underwent transplantation between December 1972 and Septem...
Is it time to change the definition of normal urinary albumin excretion? [0.03%]
重新定义正常尿白蛋白排泄率的标准时机成熟了吗？
Kristian Wachtell,Michael H Olsen
Kristian Wachtell
This Practice Point commentary discusses a recent study by Forman et al. that examined the association between baseline urinary albumin:creatinine ratio and the risk of developing hypertension among 2,179 women in the first and second Nurse...
Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease [0.03%]
克罗恩病的肠外表现： tubulointerstitial 肾炎
Aoife M Waters,Mary Zachos,Andrew M Herzenberg et al.
Aoife M Waters et al.
Background: A 12-year-old boy presented to hospital with a 6-month history of crampy pre-defecation abdominal pain, non-bloody diarrhea, anorexia and weight loss. Investigations revealed hypochromic microcytic anemia, a l...
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy? [0.03%]
洛萨坦和阿利吉仑联合治疗2型糖尿病肾病的疗效及安全性评估
Guntram Schernthaner
Guntram Schernthaner
This Practice Point commentary discusses the findings and limitations of a randomized, double-blind study conducted by Parving and colleagues. The study evaluated the renoprotective effects of dual blockade of the renin-angiotensin-aldoster...
Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease [0.03%]
降蛋白治疗需综合个体化策略以遏制肾病进展
Paul E de Jong,Gerjan Navis
Paul E de Jong
This Practice Point commentary discusses the implementation of an intensive, multifactorial intervention in patients who had proteinuria >3 g/day despite treatment with angiotensin-converting-enzyme inhibitors. In their 'Remission Clinic' i...
Valerie A Luyckx,Saraladevi Naicker
Valerie A Luyckx
The use of traditional medicine is common worldwide, with rates of use of over 80% in some populations. Considering the large number of people using traditional remedies throughout the world, it does seem that most do so without major adver...
Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease [0.03%]
慢性肾脏疾病患者的心血管疾病非传统危险因素
Jessica Kendrick,Michel B Chonchol
Jessica Kendrick
Patients with chronic kidney disease (CKD) have a reduced lifespan, and a substantial proportion of these individuals die from cardiovascular disease. Although a large percentage of patients with CKD have traditional cardiac risk factors su...
A M James Shapiro
A M James Shapiro